Although adenocarcinoma of the prostate is a leading cause of death due to cancer in men (Lytton, 1989; Dennis & Mahler, 1990) , very little has been reported on molecular or cellular biological studies of these tumours and their cells. This is in no small way because of the difficulties experienced is establishing cell lines from individual tumours, not least of which are the problem of cell contamination (Nelson-Rees et al., 1981; van Helden et al., 1988) and the presence of prostate lines which are clonal derivatives of other lines (Chen, 1993) . Furthermore, extrapolation of studies of any cell line established from tumour samples can be problematical owing to the clonal selection that invariably occurs. Since these cells represent only a fraction of the whole, many features may differ from those of other cells from the same individual. For example, this may include a shift in gene expression of even apparently prostate-specific molcules (Fong et al., 1991) . Changes in genotype and phenotype are not necessarily surprising, given that somatic mutations are increasingly being reported in malignancies.
These mutations may be detected by cytogenetic analyses, point mutation searches, target gene structural analyses or DNA fingerprint analysis. The last technique has been used to show structural differences between tumour and normal DNA from cancer patients (Armour et al., 1989; Lagoda et al., 1989) , including some prostate cancers (White et al., 1990; Bettink et al., 1992) . DNA fingerprint differences in cell lnes established from different areas of the same tumour have also been reported (Bettink et al., 1992) . In this study we report a new method to establish cell lines from bioptic/ surgical prostate samples using an extracellular matrix laid down by unrelated cells and show that very substantial somatic changes have occurred in those prostate cells clonally selected by the culture process. Fingerprint analyses were done using an M13 phage-derived sequence (pV47-2), which preferentially targets sequences located on telomeres (Longmure et al., 1989 thereafter twice per week. The medium added barely covered the explants.
Preparation of ECMflasks
Extracellular matrix (ECM)-coated 25 cm2 cell culture flasks were made according to the procedure of Golombick and Bezwoda (1991) .
Suttner cells (human ovarian carcinoma cells, a proprietary cell line from Professor Bezwoda, Department of Medicine, University of the Witwatersrand, South Africa) were grown until the cultures reached complete confluency in serum-free KSLMS medium (Kawamoto et al., 1983) containing no bovine serum albumin (BSA), insulin or transferrin (proteinfree medium). Six to eight days later, the cells were washed twice with water and then incubated with 0.25 N ammonium hydroxide until the entire cell layer had dissolved, usually within 20-30 min. The viscous solution was discarded and the underlying extracellular matrix, which remained firmly attached to the plastic surface, was ninsed with PBS until pH 7.2 was reached, after which two more rinses with water followed. The entire procedure was carried out under sterile conditions. ECM-coated cell culture flasks were stored at 4'C for 4-8 months. Before use the flasks were rinsed twice with serum-free medium.
Precautions taken to avoid cell-cell contamination The cells were grown in the laboratory which maintains the National Cancer Association's Repository for Biological Materials (NRBM). Stringent precautions regarding multiple cell cultures were observed at all times to avoid any possibility of cellular cross-contamination. The BM 1604 cells were handled by one person only, usually after hours. Supernatant fluid from the culture medium was subjected to PSA estimation using the Tandem-R assay (Hybritec Corporation). This was performed at 1, 3 and 6 months after the establishment of the cell line.
DNA fingerprinting DNA fingerpnnts were generated using a 32P-labelled M13-derived multilocus probe, PV47-2. The oligonucleotide (GTG) The DNA fingerprints were digitised for analysis using a Genius GT1212A tablet and custom-designed software.
Results
Isolation and growth of BM 1604 After 3 weeks, a number of flasks showed cells growing out from the adherent fragments. After 6 weeks some cells were detached by vigorous shaking and transferred to secondary culture. Cells grew out from fragments seeded both in serumcontaining medium and in serum-free medium on ECMcoated plates. However, from the second passage, the cells in serum-free medium became vacuolated and showed a slower growth rate. Routinely therefore, all cells were grown in RPMI-1640 medium with 5% FCS, and were subcultured by trypsiisation.
The cell line was named BM 1604 (according to the patient's initials and the date the specimen was received). Frozen stocks of the cell line were prepared for liquid nitrogen storage, and cells have been successfully thawed from these stocks.
The cells showed a typical morphology and growth pattern quite distinct from other cell lines. The cells grow initially in islands which fuse when the cultures become confluent (Figure 2 al., 1987) . Cytogenetic (chromosome) analyses were also done on the ovarian line and the prostate cell, and the results (not shown) confirm that the Suttner line used to prepare culture matrix contains two X chromosomes and is definitely of human origin, although many chromosomal rearrangements were detected. In contrast, the BM line had only one X chromosome, although no Y chromosome was detected. Many rearrangements were detected, which differed considerably from those seen in the Suttner line.
The gross differences seen in karotype analysis were confirmed by DNA fingerprint analysis. The results ( Figure  3) show that DNA from the tumour is essenially the same as that in the blood. A total of six locus-specific differences were clearly discernible between the blood and tissue sample DNA (approximately 8%), whereas a similar analysis revealed a 60% difference between the blood-derived DNA and that from the cultured cells. A similar analysis of the cultured prostate cells (BM 1604) and the supporting matrix cells (Suttner) revealed a 93% difference.
Dcos
The M13-derived multilocus probe used (Vassart et al., 1987) preferentially localises to telomeres. In spite of the relatively localised hybridisation, such multilocus probes, by virtue of their detection of multiple loci, can be useful for the detection of genetic alterations in tumours (Armour et al., 1989; Lagoda et al., 1989; White et al., 1990) or clonality in cells (Bettink et al., 1992) . The former have been detected in this way in Ca prostate samples, usually with at least one altered band (White et al., 1990) , similar to the result reported here for the blood-tissue pair analysis in samples from patient B.M.
In contrast, the established line (BM 1604) appears to vary considerably from the starting material (patient B.M. DNA). Initially, the concern was raised that cell culture contamination may have occurred from the ovarian line used to establish the ECM on which the BM cells were initially established. However, fingerprint and chromosomal analysis revealed that these lines are quite different. Although no Y chromosome was detected in the prostate-derived cells, it has been observed that the Y chromosome is sometimes lost in malignant cells or in cells from elderly men (Pierre & Hoagland, 1972 (van Helden & Wiid, 1987; van Helden et al., 1988, and unpublished observations) . This was also observed in fingerprints obtained from this line over a period of 6 months in continuous culture.
The BM 1604 cell line has an epithelial morphology, with loosely attached cells becoming more abundant with confluency. This appears to be characteristic of prostate cell lines (Kaighn et al., 1979 ). The cells demonstrate staining of cytokeratins, similar to that in PPC-1 cells (Brothman et al., 1989) , and have no or low amounts of detectable PSA, as has been reported in PC-3 and DU-145 prostate cell lines, unlike the LNCaP cell line (Skowronski et al., 1993) . The number of prostate cell lines available for study has become even more limited since PPC-1 was recently reported to be a clonal derivative of PC-3 (Chen, 1993) .
We conclude that BM 1604 is a new, unique prostatederived cell line established using a new method, which may join the ranks of the few prostate lines available for molecular and cellular analyses.
